| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc (IRWD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $7.01M | - | |
| VP | 658.0K | $2.43M | - | |
| Other | 500.5K | $1.85M | - | |
| Other | 416.6K | $1.54M | - | |
| Other | 350.4K | $1.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2018 | Consylman Gina | Chief Financial Officer | Sell | 188 | $18.21 | $3,423.48 | -0.2% | |
| Jul 6, 2018 | McCourt Thomas A66 | Chief Commercial Officer | Sale+OE | 30,000 | $20.00 | $600,000.00 | -100% | |
| Jul 3, 2018 | Gilbert Halley E | Chief Legal Officer | Sale+OE | 29,551 | $19.75 | $583,632.25 | -100% | |
| Jun 5, 2018 | Olanoff Lawrence S | Director | Sell | 2,000 | $17.62 | $35,240.00 | -4.4% | |
| Jun 5, 2018 | McHugh Julie55 | Director | Sell | 1,500 | $17.62 | $26,430.00 | -1.6% | |
| Mar 5, 2018 | Olanoff Lawrence S | Director | Sell | 2,000 | $14.05 | $28,100.00 | -6.4% | |
| Mar 5, 2018 | McHugh Julie55 | Director | Sell | 1,500 | $14.06 | $21,090.00 | -1.9% | |
| Feb 21, 2018 | Currie Mark G53 | Chief Scientific Officer | Sell | 1,634 | $14.66 | $23,954.44 | -8.3% | |
| Feb 21, 2018 | McCourt Thomas A66 | Chief Commercial Officer | Sell | 3,343 | $14.66 | $49,008.38 | -3.0% | |
| Feb 21, 2018 | Gilbert Halley E | Chief Legal Officer | Sell | 7,741 | $14.66 | $113,483.06 | -2.6% |